Neuraxpharm has acquired CNS specialty pharmaceutical company Farmax from SVUS Pharma, in a move that strengthens the firm’s European CNS leadership position by entering the Czech Republic, Slovakia and Hungary.
Neuraxpharm has expanded its pan-European footprint in Central and Eastern Europe (CEE) after acquiring central nervous system (CNS) specialty pharmaceutical company Farmax from SVUS Pharma for an undisclosed fee.
Located in Hradec Králové, Czech Republic, Farmax was the commercial division of SVUS Pharma, a pharmaceutical packaging and labelling specialist....
Melinta Therapeutics has prevailed at the Federal Circuit in a patent dispute over its reformulated intravenous antibiotic Minocin, with the appeals court upholding both infringement and validity and leaving Nexus Pharmaceuticals barred from launching a generic until 2031.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
Mounjaro, Eliquis, and Darzalex buck the Q1 trend to make gains
